Table 3.
Study | Treatment | Patients | Related complications |
---|---|---|---|
Matsumoto, 2015 [17] | NAC | 15 | Grade 3–4 adverse events: 2 neutropenia and 1 diarrhea |
NACRT | 109 | NA | |
Okuyama, 2018 [18] | NAC | 27 |
Grade 3–4 adverse events: no; Frequent toxic events:grade 1 neutropenia |
NACRT | 28 |
Grade 3–4 adverse events: no; Frequent toxic events: grade 1 diarrhea |
|
Deng, 2019 [29] | NAC | 152 | Grade 3/4 toxicities: leukopenia 9; neutropenia 15; nausea/vomiting 4; diarrhea 12 |
NACRT | 292 | Grade 3/4 toxicities: leukopenia 48; neutropenia 40; nausea/vomiting 13; diarrhea 35; radiation dermatitis 54; radiation proctitis 35; |
Note: NAC neoadjuvant chemotherapy without radiation, NACRT neoadjuvant chemoradiation therap, NA not available